Detalhe da pesquisa
1.
Brain metastasis as the first and only metastatic relapse site portends worse survival in patients with advanced HER2 + breast cancer.
Breast Cancer Res Treat
; 197(2): 425-434, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36403183
2.
Systemic Therapy Approaches for Breast Cancer Brain and Leptomeningeal Metastases.
Curr Treat Options Oncol
; 23(10): 1457-1476, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36136177
3.
Systemic management of brain metastases in HER2+ breast cancer in 2022.
Clin Adv Hematol Oncol
; 20(5): 325-336, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579591
4.
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
Breast Cancer Res Treat
; 171(3): 637-648, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29938395
5.
Multidisciplinary Management of Breast Cancer Brain Metastases.
Oncology (Williston Park)
; 30(10): 923-33, 2016 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27753060
6.
Dietary manipulation of serotonergic and dopaminergic function in C57BL/6J mice with amino acid depletion mixtures.
J Neural Transm (Vienna)
; 121(2): 153-62, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24061481
7.
Unique genomic alterations in the circulating tumor DNA of patients with solid tumors brain metastases.
Neurooncol Adv
; 6(1): vdae052, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38680992
8.
Triple Negative Breast Cancer and Brain Metastases.
Clin Breast Cancer
; 23(8): 825-831, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586926
9.
Durable responses in patients with HER2+ breast cancer and leptomeningeal metastases treated with trastuzumab deruxtecan.
NPJ Breast Cancer
; 9(1): 19, 2023 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36997605
10.
Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases.
Clin Cancer Res
; 29(1): 174-182, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36074155
11.
The Enduring Effects of COVID for Cancer Care: Learning from Real-Life Clinical Practice.
Clin Cancer Res
; 29(9): 1670-1677, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920243
12.
HER2-positive breast cancer brain metastasis: A new and exciting landscape.
Cancer Rep (Hoboken)
; 5(4): e1274, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32881421
13.
Systemic Therapy Type and Timing Effects on Radiation Necrosis Risk in HER2+ Breast Cancer Brain Metastases Patients Treated With Stereotactic Radiosurgery.
Front Oncol
; 12: 854364, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35669439
14.
Comprehensive Analysis of the Immunogenomics of Triple-Negative Breast Cancer Brain Metastases From LCCC1419.
Front Oncol
; 12: 818693, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35992833
15.
Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer.
J Immunother Cancer
; 10(2)2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121644
16.
Advances in the management of breast cancer brain metastases.
Neurooncol Adv
; 3(Suppl 5): v63-v74, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34859234
17.
Preparation of an Orthotopic, Syngeneic Model of Lung Adenocarcinoma and the Testing of the Antitumor Efficacy of Poly(2-oxazoline) Formulation of Chemo-and Immunotherapeutic Agents.
Bio Protoc
; 11(6): e3953, 2021 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33855115
18.
Preparation and Characterization of Poly(2-oxazoline) Micelles for the Solubilization and Delivery of Water Insoluble Drugs.
Bio Protoc
; 11(6): e3959, 2021 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33855119
19.
Silencing of Oncogenic KRAS by Mutant-Selective Small Interfering RNA.
ACS Pharmacol Transl Sci
; 4(2): 703-712, 2021 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33860195
20.
A Need for More Molecular Profiling in Brain Metastases.
Front Oncol
; 11: 785064, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35145903